Teikyo University Graduate School of Public Health, Tokyo, Japan.
Medical Affairs, Viatris Pharmaceuticals Japan Inc., Tokyo, Japan.
BMC Musculoskelet Disord. 2023 Apr 14;24(1):297. doi: 10.1186/s12891-023-06415-9.
Although disease-modifying properties of nonsteroidal anti-inflammatory drugs (NSAIDs) for osteoarthritis (OA) have been reported, the effects of NSAIDs on OA progression remain controversial. The purpose of this study was to investigate the effect of early initiation of oral NSAID therapy on the progression of knee OA.
In this retrospective cohort study, we extracted data of patients newly diagnosed with knee OA between November 2007 and October 2018 from a Japanese claims database. The primary outcome was the time to knee replacement (KR), and the secondary outcome was the time to composite event including joint lavage and debridement, osteotomy, or arthrodesis in addition to KR. Weighted Cox regression analysis with standardized mortality/morbidity ratio (SMR) weight was performed to compare the outcomes between patients prescribed oral NSAID (NSAID group) and those prescribed oral acetaminophen (APAP) (APAP group) early after a diagnosis of knee OA. Propensity scores were calculated using logistic regression conditioned on potential confounding factors, and SMR weights were calculated using the propensity scores.
The study population comprised 14,261 patients, who were divided into two groups as follows: 13,994 in the NSAID group and 267 in the APAP group. The mean ages of patients in the NSAID and APAP groups were 56.9 and 56.1 years, respectively. Furthermore, 62.01% and 68.16% patients in the NSAID and APAP groups, respectively, were female. The NSAID group had a reduced risk of KR compared with the APAP group in the analysis using SMR weighting (SMR-weighted hazard ratio, 0.19; 95% confidence interval, 0.05-0.78). While no statistically significant difference was found for the risk of composite event between the two groups (SMR-weighted hazard ratio, 0.56; 95% confidence interval, 0.16-1.91).
The risk of KR in the NSAID group was significantly lower than that in the APAP group after accounting for residual confounding using SMR weighting. This finding suggests that oral NSAID therapy early after the initial diagnosis is associated with a reduced risk of KR in patients with symptomatic knee OA.
虽然已经报道了非甾体抗炎药(NSAIDs)对骨关节炎(OA)具有改善病情的特性,但 NSAIDs 对 OA 进展的影响仍存在争议。本研究旨在探讨早期口服 NSAID 治疗对膝关节 OA 进展的影响。
在这项回顾性队列研究中,我们从日本的一个索赔数据库中提取了 2007 年 11 月至 2018 年 10 月间新诊断为膝关节 OA 的患者数据。主要结局是膝关节置换(KR)的时间,次要结局是包括关节灌洗和清创术、截骨术或融合术以及 KR 在内的复合事件的时间。使用标准化死亡率/发病率比(SMR)权重的加权 Cox 回归分析比较了膝关节 OA 诊断后早期口服 NSAID(NSAID 组)和口服对乙酰氨基酚(APAP)(APAP 组)患者的结局。使用逻辑回归计算潜在混杂因素条件下的倾向评分,并使用倾向评分计算 SMR 权重。
研究人群包括 14261 名患者,他们分为两组:13994 名在 NSAID 组,267 名在 APAP 组。NSAID 组和 APAP 组患者的平均年龄分别为 56.9 岁和 56.1 岁。此外,NSAID 组和 APAP 组分别有 62.01%和 68.16%的患者为女性。在使用 SMR 加权的分析中,NSAID 组的 KR 风险低于 APAP 组(SMR 加权的危险比,0.19;95%置信区间,0.05-0.78)。然而,两组之间复合事件的风险无统计学差异(SMR 加权的危险比,0.56;95%置信区间,0.16-1.91)。
在使用 SMR 加权校正残留混杂因素后,NSAID 组的 KR 风险明显低于 APAP 组。这一发现表明,在膝关节 OA 症状出现后早期口服 NSAID 治疗与 KR 风险降低相关。